Q: which diseases are more suitable for enoxaparin treatment in clinic?
A: a large number of high-quality clinical studies based on xai have established that enoxaparin is an ideal choice for patients with stable/unstable angina and st-segment elevation/non-st-segment elevation myocardial infarction. At the same time, enoxaparin can also be used for the prevention of VTE in medical treatment and the partial treatment of pulmonary embolism. It should be noted in clinical application that these two separate indications are not available for other low molecular weight heparin. Therefore, clinicians should choose drugs according to patients' disease characteristics and individual needs, and guide clinical practice based on evidence-based evidence, and finally make a reasonable choice and standard application.